Web NewDrugInformation.com


Drug - Diapid
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lypressin
Multiple ingredients are in alphabetical order.

Strength - 0.185MG/ML
The potency of the active ingredient(s), Lypressin. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Diapid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016755
The FDA assigned number to Diapid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Diapid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Diapid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Diapid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Diapid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Diapid.